摘要
目的评价兰索拉唑联合莫沙必利、茴三硫治疗反流性食管炎的疗效。方法选择反流性食管炎患者120例,随机分3组,每组各40例。A组(莫沙必利组):兰索拉唑(15 mg,口服,bid)+莫沙必利(5 mg,口服,tid);B组(茴三硫组):兰索拉唑(15 mg,口服,bid)+茴三硫(25 mg,口服,tid);C组(联合治疗组):兰索拉唑(15 mg,口服,bid)+莫沙必利(5 mg,口服,tid)+茴三硫(25 mg,口服,tid),治疗时间均为8周。结果兰索拉唑联合莫沙必利、茴三硫治疗反流性食管炎的效果明显优于莫沙必利组及茴三硫组(P<0.05)。结论兰索拉唑联合莫沙必利、茴三硫治疗反流性食管炎有较好疗效,值得临床推广。
Objective To evaluate the clinical therapeutic effect of lansoprazole combined with mosapride and anethol trithione in treatment of reflux esophagitis,Methods Choose reflux esophagitis patients 120 eases were randomly divided into three groups,each group of 40 cases each. Group A （mosapride group） ：lansoprazole （15 rag,oral,bid） ＋ mosapride（5 mg, oral, tid） , group B （ anethol trithione group） ： lansoprazole （ 15 mg, oral, bid） ＋ anethol trithione （ 25 mg, oral, tid） , and group C （combined treatment group） ：lansoprazole （15 rag,oral,bid） ＋ mosapride （5 mg,oral,tid） ＋ anethol trithione （25 mg, oral, rid）, treatment time are 8 weeks. Results The elinical therapeutic effect of lansoprazole combined with mosapride and anethol trithione in treatment of reflux esophagitis is obviously superior to the mosapride group and anethol trithione group （ P 〈0. 05）. Conclusion The clinical therapeutic effect of lansoprazole combined with mosapride and anethol, trithione in treatment of reflux esophagitis is very good,it is worth clinical promotion.
出处
《临床消化病杂志》
2013年第3期168-170,共3页
Chinese Journal of Clinical Gastroenterology
